Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 24 Jul 2024

Crotoxin induces cytotoxic effects in human malignant melanoma cells in both native and detoxified forms

in Pharmacology of Anti-Cancer Drugs

Tamires Cunha Almeida
Karina Cristina Giannotti
Lorena Morais Ribeiro Silva
Rafael Marques-Porto
Carlos DeOcesano-Pereira
Lauren Camargo
Ana Marisa Chudzinski-Tavassi
Paul Reid
Gisele Picolo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1425446

2,057 views
1 citation

Original Research

Published on 24 Jul 2024

CBX2 enhances the progression and TMZ chemoresistance of glioma via EZH2-mediated epigenetic silencing of PTEN expression

in Pharmacology of Anti-Cancer Drugs

Jian Wang
Bo Yang
Yingzhao Wang
Shuhan Liu
Changkai Ma
Jianmin Piao
Shiqiang Ma
Dehai Yu
Wei Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1430891

3,427 views
5 citations

Original Research

Published on 24 Jul 2024

The xenobiotic transporter ABCC4/MRP4 promotes epithelial mesenchymal transition in pancreatic cancer

in Pharmacology of Anti-Cancer Drugs

S. N. Gancedo
A. Sahores
N. Gómez
N. Di Siervi
M. May
A. Yaneff
M. G. de Sousa Serro
N. Fraunhoffer
N. Dusetti
J. Iovanna

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1432851

2,381 views
1 citation

Original Research

Published on 24 Jul 2024

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for sunitinib

in Pharmacology of Anti-Cancer Drugs

Xusheng Zhang
Xiuli Ren
Tianyu Zhu
Wanjin Zheng
Chengwu Shen
Cuicui Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1407709

4,285 views
6 citations

Mini Review

Published on 24 Jul 2024

Research progress on nonsteroidal anti-inflammatory drugs in the treatment of pituitary neuroendocrine tumors

in Pharmacology of Anti-Cancer Drugs

Jiaqi Li
Xinkang Shi
Tao Tang
Manxin Zhou
Feng Ye

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1407387

1,671 views
3 citations

Original Research

Published on 23 Jul 2024

Locoregional interventional therapy for hepatocellular carcinoma: radiologic and clinical factors predictive of untreatable progression and time to untreatable progression

in Pharmacology of Anti-Cancer Drugs

Zijun He
Xueying Zhang
Yucong Zhang
Jian Kong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1413696

1,771 views

Original Research

Published on 23 Jul 2024

RREB1-mediated SUMOylation enhancement promotes chemoresistance partially by transcriptionally upregulating UBC9 in colorectal cancer

in Pharmacology of Anti-Cancer Drugs

Ya-nan Deng
Ying Chen
Shan Gao
Nan Zhang
Yinheng Luo
Shu Luo
Qiu Li
Xianghui Fu
Shufang Liang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1381860

2,716 views
5 citations

Review

Published on 22 Jul 2024

Prospects of compounds of herbal plants as anticancer agents: a comprehensive review from molecular pathways

in Pharmacology of Anti-Cancer Drugs

Putri Cahaya Situmorang
Syafruddin Ilyas
Sony Eka Nugraha
Rony Abdi Syahputra
Nik Mohd Afizan Nik Abd Rahman

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1387866

7,668 views
17 citations

Original Research

Published on 22 Jul 2024

Comparison of nanovesicles derived from Panax notoginseng at different size: physical properties, composition, and bioactivity

in Pharmacology of Anti-Cancer Drugs

Xiaohang Chen
Liyu Huang
Mengyuan Zhang
Shuoqi Lin
Jing Xie
Hengyi Li
Xing Wang
Youguang Lu
Dali Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1423115

1,991 views
1 citation

Review

Published on 22 Jul 2024

The biological impact of deuterium and therapeutic potential of deuterium-depleted water

in Pharmacology of Anti-Cancer Drugs

Jiao Qu
Yufei Xu
Shuang Zhao
Ling Xiong
Jing Jing
Su Lui
Juan Huang
Hubing Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1431204

13,658 views
7 citations

Original Research

Published on 22 Jul 2024

Comprehensively prognostic and immunological analyses of GLP-1 signaling-related genes in pan-cancer and validation in colorectal cancer

in Pharmacology of Anti-Cancer Drugs

Chaojun Zhu
Yihong Lai
Chengdong Liu
Lan Teng
Yuxin Zhu
Xinyu Lin
Xinyi Fu
Qiuhua Lai
Side Liu
Xiaohan Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1387243

5,730 views
10 citations

Mini Review

Published on 19 Jul 2024

Recent advances and applications of nitroreductase activable agents for tumor theranostic

in Pharmacology of Anti-Cancer Drugs

Baoxin Shang
Zongjiang Yu
Zhengdan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1451517

4,322 views
3 citations

Review

Published on 19 Jul 2024

The impact of sarcopenia on the efficacy of PD-1 inhibitors in non-small cell lung cancer and potential strategies to overcome resistance

in Pharmacology of Anti-Cancer Drugs

Zhenchao Liu
Tianxiang Lei
Yunliang Guo
Chongwen Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1377666

3,322 views
3 citations

Original Research

Published on 19 Jul 2024

Assessing the role of statin therapy in bladder cancer: evidence from a Mendelian Randomization study

in Pharmacology of Anti-Cancer Drugs

Rongkang Li
Guixiao Huang
Yunfei Li
Mou Huang
Ying Huang
Yingrui Li
Guangzhi Li
Song Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1427318

3,348 views
7 citations

Case Report

Published on 18 Jul 2024

VKH-like uveitis during donafenib therapy for hepatocellular carcinoma: a case report and review of the literature

in Pharmacology of Anti-Cancer Drugs

Rui Liu
Guina Liu
Fang Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1401017

2,048 views
1 citation

Systematic Review

Published on 18 Jul 2024

PD-1 inhibitors in advanced esophageal squamous cell carcinoma: a survival analysis of reconstructed patient-level data

in Pharmacology of Anti-Cancer Drugs

Chunyan Yan
Wenxiu Cao
Jianghua Li
Lei Zhang
Ruigang Diao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1408458

2,682 views
1 citation